|
1
|
Gabrilovich DI and Nagaraj S:
Myeloid-derived suppressor cells as regulators of the immune
system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steinman RM: The dendritic cell system and
its role in immunogenicity. Annu Rev Immunol. 9:271–296. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steinman RM and Banchereau J: Taking
dendritic cells into medicine. Nature. 449:419–426. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Banchereau J and Steinman RM: Dendritic
cells and the control of immunity. Nature. 392:245–252. 1998.
View Article : Google Scholar
|
|
5
|
Steinman RM and Nussenzweig MC: Avoiding
horror autotoxicus: the importance of dendritic cells in peripheral
T cell tolerance. Proc Natl Acad Sci USA. 99:351–358. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Littman DR and Rudensky AY: Th17 and
regulatory T cells in mediating and restraining inflammation. Cell.
140:845–858. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang M, Tang H, Guo Z, et al: Splenic
stroma drives mature dendritic cells to differentiate into
regulatory dendritic cells. Nat Immunol. 5:1124–1133. 2004.
View Article : Google Scholar
|
|
8
|
Liu Q, Zhang C, Sun A, Zheng Y, Wang L and
Cao X: Tumor-educated CD11bhighIalow regulatory dendritic cells
suppress T cell response through arginase I. J Immunol.
182:6207–6216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bronte V and Zanovello P: Regulation of
immune responses by L-arginine metabolism. Nat Rev Immunol.
5:641–654. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rodríguez PC and Ochoa AC: Arginine
regulation by myeloid derived suppressor cells and tolerance in
cancer: mechanisms and therapeutic perspectives. Immunol Rev.
222:180–191. 2008.PubMed/NCBI
|
|
11
|
Kusmartsev S, Nefedova Y, Yoder D and
Gabrilovich DI: Antigen-specific inhibition of CD8+ T cell response
by immature myeloid cells in cancer is mediated by reactive oxygen
species. J Immunol. 172:989–999. 2004.
|
|
12
|
Yang R, Cai Z, Zhang Y, Yutzy WH 4th, Roby
KF and Roden RB: CD80 in immune suppression by mouse ovarian
carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res.
66:6807–6815. 2006.PubMed/NCBI
|
|
13
|
Huang B, Pan PY, Li Q, et al: Gr-1+CD115+
immature myeloid suppressor cells mediate the development of
tumor-induced T regulatory cells and T-cell anergy in tumor-bearing
host. Cancer Res. 66:1123–1131. 2006.
|
|
14
|
Delano MJ, Scumpia PO, Weinstein JS, et
al: MyD88-dependent expansion of an immature GR-1(+)CD11b(+)
population induces T cell suppression and Th2 polarization in
sepsis. J Exp Med. 204:1463–1474. 2007.PubMed/NCBI
|
|
15
|
Liu C, Zhang C, Lu H, et al: Poly(I:C)
induce bone marrow precursor cells into myeloid-derived suppressor
cells. Mol Cell Biochem. 358:317–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsujimoto H, Efron PA, Matsumoto T, et al:
Maturation of murine bone marrow-derived dendritic cells with
poly(I:C) produces altered TLR-9 expression and response to CpG
DNA. Immunol Lett. 107:155–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harty JT and Bevan MJ: Specific immunity
to Listeria monocytogenes in the absence of IFN gamma. Immunity.
3:109–117. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang H, Guo Z, Zhang M, Wang J, Chen G and
Cao X: Endothelial stroma programs hematopoietic stem cells to
differentiate into regulatory dendritic cells through IL-10. Blood.
108:1189–1197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia S, Guo Z, Xu X, Yi H, Wang Q and Cao
X: Hepatic microenvironment programs hematopoietic progenitor
differentiation into regulatory dendritic cells, maintaining liver
tolerance. Blood. 112:3175–3185. 2008. View Article : Google Scholar
|
|
20
|
Li Q, Guo Z, Xu X, Xia S and Cao X:
Pulmonary stromal cells induce the generation of regulatory DC
attenuating T-cell-mediated lung inflammation. Eur J Immunol.
38:2751–2761. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamamoto S, Yamamoto T, Kataoka T,
Kuramoto E, Yano O and Tokunaga T: Unique palindromic sequences in
synthetic oligonucleotides are required to induce IFN [correction
of INF] and augment IFN-mediated [correction of INF] natural killer
activity. J Immunol. 148:4072–4076. 1992.PubMed/NCBI
|
|
22
|
Krieg AM, Yi AK, Matson S, et al: CpG
motifs in bacterial DNA trigger direct B-cell activation. Nature.
374:546–549. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klinman DM, Yi AK, Beaucage SL, Conover J
and Krieg AM: CpG motifs present in bacteria DNA rapidly induce
lymphocytes to secrete interleukin 6, interleukin 12, and
interferon gamma. Proc Natl Acad Sci USA. 93:2879–2883. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hemmi H, Takeuchi O, Kawai T, et al: A
Toll-like receptor recognizes bacterial DNA. Nature. 408:740–745.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harty JT, Lenz LL and Bevan MJ: Primary
and secondary immune responses to Listeria monocytogenes. Curr Opin
Immunol. 8:526–530. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krieg AM, Love-Homan L, Yi AK and Harty
JT: CpG DNA induces sustained IL-12 expression in vivo and
resistance to Listeria monocytogenes challenge. J Immunol.
161:2428–2434. 1998.PubMed/NCBI
|
|
27
|
Pan PY, Wang GX, Yin B, et al: Reversion
of immune tolerance in advanced malignancy: modulation of
myeloid-derived suppressor cell development by blockade of
stem-cell factor function. Blood. 111:219–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sinha P, Clements VK, Fulton AM and
Ostrand-Rosenberg S: Prostaglandin E2 promotes tumor progression by
inducing myeloid-derived suppressor cells. Cancer Res.
67:4507–4513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serafini P, Carbley R, Noonan KA, Tan G,
Bronte V and Borrello I: High-dose granulocyte-macrophage
colony-stimulating factor-producing vaccines impair the immune
response through the recruitment of myeloid suppressor cells.
Cancer Res. 64:6337–6343. 2004. View Article : Google Scholar
|
|
30
|
Bunt SK, Yang L, Sinha P, Clements VK,
Leips J and Ostrand-Rosenberg S: Reduced inflammation in the tumor
microenvironment delays the accumulation of myeloid-derived
suppressor cells and limits tumor progression. Cancer Res.
67:10019–10026. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gabrilovich D, Ishida T, Oyama T, et al:
Vascular endothelial growth factor inhibits the development of
dendritic cells and dramatically affects the differentiation of
multiple hematopoietic lineages in vivo. Blood. 92:4150–4166.
1998.
|
|
32
|
Greifenberg V, Ribechini E, Rössner S and
Lutz MB: Myeloid-derived suppressor cell activation by combined LPS
and IFN-gamma treatment impairs DC development. Eur J Immunol.
39:2865–2876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
D’Amico A and Wu L: The early progenitors
of mouse dendritic cells and plasmacytoid predendritic cells are
within the bone marrow hemopoietic precursors expressing Flt3. J
Exp Med. 198:293–303. 2003.
|
|
34
|
Karsunky H, Merad M, Cozzio A, Weissman IL
and Manz MG: Flt3 ligand regulates dendritic cell development from
Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic
cells in vivo. J Exp Med. 198:305–313. 2003.
|
|
35
|
Bronte V, Apolloni E, Cabrelle A, et al:
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor
capable of activating or suppressing CD8(+) T cells. Blood.
96:3838–3846. 2000.
|
|
36
|
Terrazas LI, Walsh KL, Piskorska D,
McGuire E and Harn DA Jr: The schistosome oligosaccharide
lacto-N-neotetraose expands Gr1(+) cells that secrete
anti-inflammatory cytokines and inhibit proliferation of naive
CD4(+) cells: a potential mechanism for immune polarization in
helminth infections. J Immunol. 167:5294–5303. 2001.PubMed/NCBI
|
|
37
|
Gómez-García L, López-Marín LM, Saavedra
R, Reyes JL, Rodríguez-Sosa M and Terrazas LI: Intact glycans from
cestode antigens are involved in innate activation of myeloid
suppressor cells. Parasite Immunol. 27:395–405. 2005.
|
|
38
|
Brys L, Beschin A, Raes G, et al: Reactive
oxygen species and 12/15-lipoxygenase contribute to the
antiproliferative capacity of alternatively activated myeloid cells
elicited during helminth infection. J Immunol. 174:6095–6104. 2005.
View Article : Google Scholar
|
|
39
|
Mencacci A, Montagnoli C, Bacci A, et al:
CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1
immunity in mice with candidiasis. J Immunol. 169:3180–3190.
2002.
|
